1. Aapro, M, Zulian, G, Alberto, P, Bruno, R, Oulid-Aissa, D & Le Bail, N (1992). Phase I and pharmacokinetic study of RP56976 in a new ethanol free formulation. Ann Oncol 3: (abstract 208)
2. Armand, JP & Couteau, C (1995). Chemotherapy in head and neck treatment. Eur J Cancer 5: 819–822.
3. Bissery, MC, Guenard, D & Gueritte-Voegelein, F (1991). Experimental antitumor activity of taxotere, a taxol analogue. Cancer Res 51: 4845–4852.
4. Bissett, D, Setanoians, A, Cassidy, J, Graham, MA, Chadwick, GA, Wilson, P, Auzannet, V, Le Bail, N, Kaye, SB & Kerr, DJ (1993). Phase I and pharmacokinetic study of taxotere administered as infusion. Cancer Res 53: 523–527.
5. Braakhuis, BJM, Kagel, A & Welters, MJP (1994). The growth inhibiting effect of docetaxel (taxotere) in head and neck squamous cell carcinoma xenografts. Cancer Lett 81: 151–154.